Brief: Bellus Health Says Completed Enrollment In Phase 2 Relief Trial Of Blu-5937 For Refractory Chronic Cough

BELLUS Health

19/03/2020 11:06

March 19 (Reuters) - BELLUS Health Inc  BLU.TO :
    * BELLUS HEALTH ANNOUNCES COMPLETION OF ENROLLMENT IN PHASE
2
RELIEF TRIAL OF BLU-5937 FOR THE TREATMENT OF REFRACTORY CHRONIC
COUGH
    * BELLUS HEALTH INC - ON TRACK TO REPORT TOPLINE DATA FROM
RELIEF
TRIAL IN MID-2020

Source text for Eikon:  ID:nBw2kx1SZa 
Further company coverage:  BLU.TO 

 ((Briefs@thomsonreuters.com;))